WO2026043458 - A CAPSULE FORMULATION COMPRISING MİGALASTAT
National phase entry is expected:
Publication Number
WO/2026/043458
Publication Date
26.02.2026
International Application No.
PCT/TR2025/050997
International Filing Date
20.08.2025
Title **
[English]
A CAPSULE FORMULATION COMPRISING MİGALASTAT
[French]
FORMULATION DE GÉLULE COMPRENANT DU MİGALASTAT
Applicants **
SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
Inventors
SUNEL, Fatih
ATAK, Fadime Bilgehan
GULER, Tolga
GOKSEN, Elif
OZTAS, Necla
Priority Data
2024/011147
23.08.2024
TR
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
Turkpatent
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1987 | |
| EPO | Filing, Examination, Granting | 9177 | |
| Japan | Filing, Examination, Granting | 2037 | |
| South Korea | Filing, Examination, Granting | 1859 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
19,800
Contact Us
Abstract[English]
The present invention relates to a capsule formulation comprising migalastat hydrochloride and at least one lubricant, wherein the lubricant is sodium stearyl fumarate. The process is simple, rapid, cost effective, time-saving and industrially convenient process and is created to eliminate the disadvantages of active ingredient.[French]
La présente invention concerne une formulation de gélule comprenant du chlorhydrate de migalastat et au moins un lubrifiant, le lubrifiant étant du fumarate de stéaryle sodique. Le procédé est simple, rapide, économique, économe en temps et industriellement pratique et est créé pour éliminer les inconvénients du principe actif.